A Prospective, Multicenter, Post-Market Surveillance Study on a Modular SI Joint Fusion System
6-MONTH INTERIM RESULTS
Published in Pain Physician Journal, December 2025; Vol. 28, Issue S7
91.67%
of Patients Reported Improvement in Both Pain & Function at 6 Months
Clinical Outcomes
SPARTAN Study: 6-Month Interim Results
The SPARTAN Study is a prospective, multicenter, post-market surveillance study on a Modular SI Joint Fusion System, designed to assess patient-reported pain and functional outcomes following lateral-oblique SI joint fusion with the TransLoc 3D System. Interim findings from the SPARTAN study summarize patient-reported changes in pain and function at 6 months.
To evaluate the safety and clinical outcomes associated with the TransLoc 3D system, an ongoing prospective, multicenter study is collecting patient-reported pain and functional outcomes.
Interim 6-month findings present observed changes in pain and function to date, with no device- or procedure-related adverse events reported through the 6-month follow-up period.
Study Snapshot
Prospective, Multicenter Design
17 U.S. Clinical Sites
72 Patients with 6-month Interim Outcomes
Dual-Screw, Lateral-Oblique Approach
Real-World Patient Population
Key Clinical Outcomes at 6 Months:
60%
Average Patient-Reported Pain Improvement
Numerical Rating Scale (NRS) pain scores improved 57% at 3 months and 60% at 6 months
70.83% of patients achieved ≥50% pain improvement at 6 months
49%
Average Patient-Reported Functional Improvement
Oswestry Disability Index (ODI) scores improved 44% at 3 months and 49% at 6 months
91.67% of patients improved in both pain and function
0
Device-related AEs, Procedure-related AEs/SAEs
No Adverse Events Reported
At the time of the interim analysis, no device- or procedure-related adverse events, procedural complications, or revisions had been reported.
Real-World Patient Population
17
U.S. Pain Centers
114
Patients Treated
64%
Aged 65 or Older
67
Mean Age
70%
Female Patients
Explore the Clinical Data
Whether you’re reviewing clinical data or learning more about SI joint fusion, the SPARTAN Study and related resources are available to support informed conversations and decision-making.
Reported outcomes are based on interim findings from a prospective clinical study. Individual patient results may vary. Treatment decisions should be based on a comprehensive clinical evaluation and physician judgment.
This website uses cookies to enhance user experience and analyze performance and traffic. We also share information about your site use with our social media, advertising, and analytics partners. You can learn more about cookies by clicking “Privacy Policy.”